Vaccines
7 October 2024
Johnson & Johnson to Discontinue Phase 2 Field Study Evaluating Investigational Antiviral for the Prevention of Dengue2 October 2024
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-140323 September 2024
Vicebio Announces $100 Million Series B Financing and Initiation of Phase 1 Clinical Study of RSV/hMPV Bivalent Vaccine20 September 2024
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union20 September 2024
Aegis Life and Entos Complete Phase 1 Enrollment of Clinical Trial for COVID-19 Vaccine Booster18 September 2024
HDT Bio to Help Spearhead RNA Vaccine Development in National Pandemic Preparedness Initiative17 September 2024
AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease17 September 2024
MinervaX and Wacker Biotech Announce Manufacturing Collaboration for Prophylactic Vaccine Targeting Group B Streptococcus16 September 2024
Evaxion reports convincing one-year data from phase 2 trial on AI-designed personalized cancer vaccine EVX-0112 September 2024
Moderna R&D Day Highlights Progress and Strategic Priorities12 September 2024
GSK announces positive headline data from phase II seasonal influenza mRNA vaccine programme12 September 2024
GSK provides update on phase I/II therapeutic herpes simplex virus (HSV) vaccine trial10 September 2024
Alopexx Announces Collaboration with Bharat Biotech for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV032810 September 2024
Osivax and KM Biologics Enter Exclusive License Option Agreement for Broad-Spectrum “Universal” Influenza Vaccine in Japan9 September 2024
Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B23 September 2024
Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine CandidateNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports